"2019年10月より白内障日帰り手術を開始します"

During the past decade, Hashida Eye Clinic conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Hashida Eye Clinic" are "Open Angle Glaucoma, Ocular Hypertension" (1 trials) and "Primary Open Angle Glaucoma, Ocular Hypertension" (1 trials). Many other conditions were trialed in "Hashida Eye Clinic" in a lesser frequency.

Most popular intervention types in "Hashida Eye Clinic" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "STN1012600 ophthalmic solution 0.002%" (2 trials), "Latanoprost ophthalmic solution 0.005%" (1 trials) and "STN1012600 ophthalmic solution 0.002% and Timolol ophthalmic solution 0.5%" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hashida Eye Clinic" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Hashida Eye Clinic". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Hashida Eye Clinic, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Hashida Eye Clinic, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".